CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash Flows From Operating Activities
Net (loss) income	$ (676.9)	$ 46.9
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization, including impairments of finite-lived intangible assets	1,681.9	1,042.0
Amortization and write-off of debt discounts and debt issuance costs	56.6	103.2
In-process research and development impairments	14.5	12.3
Acquisition accounting adjustment on inventory sold	36.4	70.5
Gain on disposal of assets and businesses, net	(11.0)	0.0
Acquisition-related contingent consideration	9.3	18.8
Allowances for losses on accounts receivable and inventories	52.5	26.8
Deferred income tax (benefit) expense	(164.6)	37.7
(Reductions) additions to accrued legal settlements	(32.7)	6.3
Payments of accrued legal settlements	(51.4)	(5.9)
Loss on deconsolidation	18.4	0.0
Share-based compensation	97.2	60.9
Tax expense (benefit) from share-based compensation	1.4	(25.6)
Foreign exchange (gain) loss	(15.5)	65.6
Loss on extinguishment of debt	0.0	20.0
Payment of contingent consideration adjustments, including accretion	(7.9)	(12.1)
Other	(9.5)	(9.9)
Changes in operating assets and liabilities:
Trade receivables	(43.2)	(308.8)
Inventories	(145.1)	(139.3)
Prepaid expenses and other current assets	161.7	(163.5)
Accounts payable, accrued and other liabilities	34.1	55.7
Net cash provided by operating activities	1,006.2	901.6
Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired	(18.5)	(13,885.9)
Acquisition of intangible assets and other assets	(10.3)	(58.0)
Purchases of property, plant and equipment	(128.3)	(112.6)
Reduction of cash due to deconsolidation	(30.2)	0.0
Proceeds from sales and maturities of short-term investments	0.0	17.7
Net settlement of assumed derivative contracts	0.0	184.6
Settlement of foreign currency forward exchange contracts	0.0	(26.3)
Purchases of marketable securities	(1.4)	0.0
Proceeds from sale of marketable securities	15.2	0.0
Proceeds from sale of assets and businesses, net of costs to sell	111.4	0.0
Increase in restricted cash and cash equivalents	0.0	(5.2)
Net cash used in investing activities	(62.1)	(13,885.7)
Cash Flows From Financing Activities
Issuance of long-term debt, net of discount	1,220.0	16,925.8
Repayments of long-term debt	(1,273.1)	(1,358.2)
Short-term debt borrowings	2.2	5.9
Short-term debt repayments	(1.9)	(5.0)
Repayments of convertible notes assumed	0.0	(3,122.8)
Issuance of common stock, net	0.0	1,433.4
Repurchases of common shares	0.0	(50.0)
Proceeds from exercise of stock options	0.7	22.1
Tax (expense) benefit from share-based compensation	(1.4)	25.6
Payment of employee withholding tax upon vesting of share-based awards	(7.3)	(61.5)
Payments of contingent consideration	(44.4)	(81.0)
Payments of deferred consideration	(516.1)	0.0
Payments of financing costs	(65.2)	(101.7)
Other	(5.8)	(1.0)
Net cash (used in) provided by financing activities	(692.3)	13,631.6
Effect of exchange rate changes on cash and cash equivalents	3.3	(12.1)
Net increase in cash and cash equivalents	255.1	635.4
Cash and cash equivalents, beginning of period	597.3	322.6
Cash and cash equivalents, end of period	852.4	958.0
Non-Cash Investing and Financing Activities
Acquisition of businesses, contingent and deferred consideration obligations at fair value (Restated)	0.0	(635.8)
Acquisition of businesses, debt assumed	$ 0.0	$ (3,123.1)